Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Association of glial and neuronal degeneration markers with Alzheimer’s disease cerebrospinal fluid profile and cognitive functions ; volume:12 ; number:1 ; day:4 ; month:8 ; year:2020 ; pages:1-14 ; date:12.2020
Alzheimer's research & therapy ; 12, Heft 1 (4.8.2020), 1-14, 12.2020
- Urheber
-
Teitsdottir, Unnur D.
Jonsdottir, Maria K.
Lund, Sigrun H.
Darreh-Shori, Taher
Snaedal, Jon
Petersen, Petur H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-020-00657-8
- URN
-
urn:nbn:de:101:1-2020092922574706580213
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Teitsdottir, Unnur D.
- Jonsdottir, Maria K.
- Lund, Sigrun H.
- Darreh-Shori, Taher
- Snaedal, Jon
- Petersen, Petur H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration
“Glial inhibition” of memory in Alzheimer’s disease
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Glial activation and inflammation along the Alzheimer’s disease continuum
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration
“Glial inhibition” of memory in Alzheimer’s disease
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Glial activation and inflammation along the Alzheimer’s disease continuum
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease
Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer’s disease
Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration
“Glial inhibition” of memory in Alzheimer’s disease
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Glial activation and inflammation along the Alzheimer’s disease continuum
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers